metoclopramide has been researched along with raclopride in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liljefors, T; Pettersson, I | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Fang, X; Hu, Z; Levant, B; Min, J; Varady, J; Wang, S; Wu, X | 1 |
| Budygin, EA; Gaĭnetdinov, RR; Kovalev, GI; Kudrin, VS; Raevskiĭ, KS | 1 |
| Bogdanov, MB; Budygin, EA; Gaĭnetdinov, RR; Kovalev, GI; Kudrin, VS; Raevskiĭ, KS | 1 |
| Bogdanov, MB; Guinetdinov, RR; Kudrin, VS; Rayevsky, KS | 1 |
| Akçali, DT; Bolay, H; Doğanay Aydin, H; Vuralli, D | 1 |
7 other study(ies) available for metoclopramide and raclopride
| Article | Year |
|---|---|
Conformational analysis of dopamine D-2 receptor antagonists of the benzamide series in relation to a recently proposed D-2 receptor-interaction model.
Topics: Benzamides; Models, Molecular; Molecular Conformation; Receptors, Dopamine; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship | 1992 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.
Topics: Algorithms; Binding Sites; Computational Biology; Crystallography, X-Ray; Databases, Protein; Humans; Kinetics; Ligands; Lipid Bilayers; Models, Molecular; Molecular Conformation; Mutation; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Solvents; Structure-Activity Relationship; Tetrahydronaphthalenes; Water | 2003 |
[Different effects of typical and atypical neuroleptics on K+-stimulated dopamine release from isolated rat striatum].
Topics: Animals; Antipsychotic Agents; Carbolines; Clozapine; Corpus Striatum; Dopamine; Dopamine Antagonists; In Vitro Techniques; Male; Metoclopramide; Potassium; Raclopride; Rats; Rats, Wistar; Remoxipride; Salicylamides; Stimulation, Chemical; Sulpiride; Thioridazine; Tiapamil Hydrochloride; Trifluoperazine | 1992 |
[A comparative study of the neurochemical profiles of remoxipride, raclopride and metoclopramide activity].
Topics: Animals; Biogenic Monoamines; Brain; Brain Chemistry; Dopamine D2 Receptor Antagonists; Male; Metoclopramide; Psychotropic Drugs; Raclopride; Rats; Remoxipride; Salicylamides; Time Factors | 1992 |
Remoxipride and raclopride differ from metoclopramide by their effects on striatal dopamine release and biosynthesis in rats.
Topics: Animals; Antipsychotic Agents; Corpus Striatum; Dopamine; Male; Metoclopramide; Raclopride; Rats; Rats, Wistar; Remoxipride; Salicylamides | 1994 |
Metoclopramide inhibits trigeminovascular activation:evidence for effective acute attack treatment in migraine.
Topics: Animals; Brain Chemistry; Cortical Spreading Depression; Disease Models, Animal; Male; Metoclopramide; Migraine Disorders; Proto-Oncogene Proteins c-fos; Raclopride; Rats; Rats, Wistar; Trigeminal Caudal Nucleus | 2017 |